Lundbeck

Lundbeck is a global biopharmaceutical company specialized in brain diseases. We are dedicated to advancing brain health and transforming lives. To fulfill this purpose, Lundbeck is engaged in the research, development, manufacturing, and commercialization of pharmaceuticals across the world. For more than 70 years, Lundbeck has been at the forefront of neuroscience research.

  • Our commitment is to empower patients to give them the tools and resources they need to understand their disease and its unfolding.
  • Our commitment is to continuously challenge status quo and push our science further to make real differences for patients.
  • Our commitment is to families to bring evidence-based data, visibility and support to their work in managing a chronic disease.
  • Our commitment is to communities to end the stigma, fear, and silence that surrounds brain diseases.
  • Our commitment is to society, to increase access to medicines for the most vulnerable, to act responsibly towards the environment and to behave with respect and integrity in everything we do.

Offices in:

  • Deerfield, IL - Lundbeck US Home Office
  • La Jolla, CA - Lundbeck La Jolla Research Center, Inc.
  • Bothell, WA - Lundbeck Seattle BioPharmaceuticals, Inc

6 Parkway North
Deerfield, IL 60015
  • Featured Employer

A highly specialized pharmaceutical company that has conducted neuroscience research for more than 70 years. We develop innovative treatments to restore brain health and transform the lives of millions of people worldwide.

Global leadership in brain health. Whatever your area of specialization, you will be part of our company-wide commitment to develop and advance treatments that improve the lives of people with brain disease.

A culture of innovation, collaboration, and respect. We inspire curiosity, expect integrity, and pursue our achievements through knowledge-sharing, patient engagement, and the passion to deliver our end goal.

We understand we carry a huge responsibility for the societies we serve, and use our knowledge and voice to raise awareness, challenge standards, and increase opportunities – for patients and each other. We are at the forefront of treatment innovation, and together we continue to make a difference to people living with brain diseases.

As one way we invest in your career, we offer our employees a competitive compensation and benefit package that matches benchmark and general market conditions in our individual business locations.

The success of our strategy, “Expand and Invest to Grow Lundbeck” hinges on our combined competencies – and competence hinges on highly qualified and motivated employees. Our Employee Satisfaction Survey (ESS) gives us the pulse on employee motivation by asking about key elements in our work lives including management, work climate and development opportunities. We follow up on the ESS with concrete initiatives aimed at maintaining our focus on our unique workplace culture and providing personalized and aligned development opportunities for our employees.

We believe that if we build an inclusive, equity-focused organization, diversity will follow.

In simple terms, diversity is the mix. Inclusion is making the mix work. Equity is making sure we are fair and impartial in that process.

Diversity matters, and equity and inclusion create powerful organizations

To ensure that we reflect the diversity of our patients and their needs, we are focused on creating the context, culture, and systems where all Lundbeck employees - no matter who and where they are - can be their authentic self and perform at their best. In practice, this means that individuals feel empowered not despite their differences, but because of them.

We know that people are sometimes put into boxes - some of these boxes are of our own choosing and some of these boxes are chosen for us. For this reason, Lundbeck is taking a systematic, business-led approach to DE&I that looks into and breaks down these boxes. Our bold action on inclusion includes an ambitious two-year plan that enables equality of opportunity through fairness and transparency, promotes openness, tackles bias and discrimination, and fosters belonging through our unique Lundbeck culture. From the highest levels of Lundbeck to the shop floor, we are working to ensure DE&I is an integrated practice and mindset.

Four Lundbeck employees sit around a small table

Lundbeck offers a competitive benefits package that includes:

  • Medical, dental, vision effective day 1 of employment
  • Generous vacation, sick leave, holiday shut down and company paid holidays
  • 401(k) match with immediate vesting
  • Non-Contributory 401(k) Employer Contribution
  • Parental Leave
  • Hybrid work model for office-based roles

To view more details about our Benefits, please click here.

Through our sustainability strategy, we mitigate business risks, reduce negative impacts, and address societal challenges where possible. We remain committed to UN Global Compact Principles and contribute to seven of the 17 UN Sustainable Development Goals.

Lundbeck became a signatory to the UN Global Compact in 2009. We continue to promote initiatives that demonstrate our commitment to the 10 principles on human and labour rights, environment protection and anti-corruption.

Executive Management assesses Lundbeck’s business risks and opportunities and establishes our sustainability targets as communicated in our annual report.

We release an annual sustainability report describing in detail our sustainability performance and targets. For over a decade, we have reported on our sustainability efforts, challenges and contributions to our business, stakeholders and the societies we operate within.

  • 2025 BPTW Badge - RBG.png
  • 2024 Best Places to Work - Transparent
  • USA Today Top Work Places.png
  • Top Workplaces Chicago.png
  • Great Places to Work.png
  • Top Diversity Employer.png
  • Top Work Places 2023.png
  • USA Today Comp and Benefits
  • USA Today DEI.png
  • USA Today Employee Appreciation.png
  • USA Today Work Life.png
  • USA Today Well Being.png
  • USA Today Pro Dev.png
  • USA Today Woman Led.png
NEWS
Female leaders in the biopharma industry may further promote diversity and inclusion at the workplace and serve as role models for young female professionals. Here is a list of 16 of the highest-paid female CEOs in biopharma.
It was a moderately busy week for clinical trial news, with some particularly interesting announcements related COVID-19 vaccine trials. Here’s a look.
Denmark-based Lundbeck discontinued a mid-stage proof of concept study of a schizophrenia drug following an interim analysis of data that indicated the study will not achieve statistical significance in its primary endpoint.
Lundbeck stated that it is optimizing its research and development organization to strengthen and advance its pipeline.
Biopharma companies from across the globe provide updates to their business operations and pipelines.
50 million people worldwide live with symptomatic Alzheimer’s, which has no cure. In honor of September 21st being World Alzheimer’s Day, we evaluated the current therapies, drugs in the pipeline and disease outlook.
Discngine announces that Lundbeck has selected its proprietary 3decision® collaborative platform to manage the pharma company’s structural knowledge related to protein and ligand 3D structures.
The government charged the three companies with using charitable foundations they financially supported to finance copays of Medicare and Medicaid patients, which is a violation of law.
Incidence of Alzheimer’s disease is projected to double in the next 40 years unless a cure or preventive measures are found. The U.S. Centers for Disease Control and Prevention published a new report in the journal Alzheimer’s & Dementia projecting the disease’s likely expansion, and for the first time, forecasted the disease by race and ethnicity.
JOBS
IN THE PRESS